Pilot Intervention to Improve Adherence to Dabigatran for Patients With Atrial Fibillation
Phase of Trial: Phase III
Latest Information Update: 08 Aug 2018
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Stroke; Thromboembolism
- Focus Therapeutic Use
- 14 Aug 2013 Planned End Date changed from 1 Dec 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 28 Feb 2013 Planned End Date changed from 1 Jan 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 23 Apr 2012 New trial record